Milatuzumab Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
STRO | D | Sutro Biopharma, Inc. | 9.23 | |
BNOX | F | Bionomics Limited | -1.06 |
Related Industries: Biotechnology
Related Stock Lists:
Antineoplastic Drugs
Cancer
Cancer Treatment
Clinical Medicine
Alzheimer's Disease
Antibodies
Anxiolytics
Autoimmune Disorders
Biology
Biopharmaceutical
Camidanlumab Tesirine
Central Nervous System Disorders
Cognitive Impairment
Drug Discovery
Drugs
Endometrial Cancer
Hodgkin Lymphoma
Immune Disorders
Immunogen
Immunology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.28 | |
QQQS | A | Invesco NASDAQ Future Gen 200 ETF | 0.39 | |
SBIO | B | ALPS Medical Breakthroughs ETF | 0.19 | |
IWC | B | iShares Microcap ETF | 0.07 | |
FESM | B | Fidelity Enhanced Small Cap ETF | 0.05 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Antineoplastic Drugs
Cancer
Cancer Treatment
Clinical Medicine
Alzheimer's Disease
Antibodies
Anxiolytics
Autoimmune Disorders
Biology
Biopharmaceutical
Camidanlumab Tesirine
Central Nervous System Disorders
Cognitive Impairment
Drug Discovery
Drugs
Endometrial Cancer
Hodgkin Lymphoma
Immune Disorders
Immunogen
Immunology
- Milatuzumab
Milatuzumab (or hLL1) is an anti-CD74 humanized monoclonal antibody for the treatment of multiple myeloma non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.The drug is the first anti-CD74 antibody that has entered into human testing and is currently being studied for the treatment of multiple myeloma. Milatuzumab has received orphan drug designation from the Food and Drug Administration in the United States for the treatment of multiple myeloma and chronic lymphocytic leukemia.
Milatuzumab was developed by Immunomedics, Inc, (Morris Plains NJ USA).
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles